New, Lower Cost Epinephrine Pre-Filled Syringe Approved By FDA

☞ | View the text of this post. Exclusively available to ASQ Members.

Adamis Pharmaceuticals Corporation (Adamis) announced that the U.S. Food and Drug Administration (FDA) has approved Adamis’ epinephrine injection, USP, 1:1000 (0.3 mg pre-filled single dose syringe) (PFS) for the emergency treatment of allergic reactions (Type I) including anaphylaxis. The FDA has also approved the PFS trade name of Symjepi.

Symjepi provides two single dose syringes of epinephrine (adrenaline), which is considered the drug of choice for immediate administration in acute anaphylactic reactions to insect stings or

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *